Zhengdong Cai
Papers
1
Total Citations
2
H-Index
1
About
Zhengdong Cai is a pioneering researcher at the intersection of biomedical engineering and oncology, with a primary focus on developing advanced drug delivery systems for cancer therapy. His most notable work centers on magnetically driven hydrogel microrobots, a cutting-edge approach to active targeting in osteosarcoma treatment. In his highly cited 2024 paper, Cai introduced a novel strategy to overcome the limitations of conventional therapies—specifically, the lack of specific membrane receptors in osteosarcoma cells that impede effective targeted drug delivery. By engineering microrobots that can be precisely controlled via magnetic fields, he demonstrated enhanced therapeutic efficacy of anlotinib, a tyrosine kinase inhibitor, against this aggressive bone cancer. This work addresses the critical challenge of high mortality and disability rates associated with osteosarcoma, offering a promising pathway for more precise and less invasive treatments. With 2 citations in its first year, Cai’s research is gaining traction for its innovative integration of robotics and biomaterials. His contributions exemplify a forward-thinking approach to active targeting, positioning him as an emerging leader in the field of cancer nanomedicine and microrobotics.
Research Focus
Key Achievements
Top Papers
- 1